Additional file 1 of Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli (2021)
Attributed to:
The Future Vaccine Manufacturing Research Hub (Vax-Hub)
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.6084/m9.figshare.14670164
Type: Other